Schedule 13G ownership disclosure

DERMATA THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 249845504

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIGGER CAPITAL FUND L P

    Shares: 242,832.00 · Class: 4.90%

  • Bigger Capital Fund GP, LLC

    Shares: 242,832.00 · Class: 4.90%

  • District 2 Capital Fund LP

    Shares: 171,232.00 · Class: 3.46%

  • District 2 Capital LP

    Shares: 171,232.00 · Class: 3.46%

  • District 2 GP LLC

    Shares: 171,232.00 · Class: 3.46%

  • District 2 Holdings LLC

    Shares: 171,232.00 · Class: 3.46%

  • Bigger Michael

    Shares: 414,064.00 · Class: 8.36%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-26-002901
Form type
SCHEDULE 13G
Filer
Dermata Therapeutics, Inc.
CIK
CIK 1853816
Filed
Nov 02, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub